Please login to the form below

Not currently logged in
Email:
Password:

tezepelumab

This page shows the latest tezepelumab news and features for those working in and with pharma, biotech and healthcare.

FDA grants priority review for AZ, Amgen’s tezepelumab for asthma

FDA grants priority review for AZ, Amgen’s tezepelumab for asthma

The companies’ FDA submission for tezepelumab for the treatment of severe asthma patients is based on results from the PATHFINDER clinical programme. ... In September 2018, tezepelumab received a breakthrough therapy designation (BTD) from the FDA in

Latest news

More from news
Approximately 5 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...